Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial.
Pérez-Castrillón JL, Dueñas-Laita A, Brandi ML, Jódar E, Del Pino-Montes J, Quesada-Gómez JM, Cereto Castro F, Gómez-Alonso C, Gallego López L, Olmos Martínez JM, Alhambra Expósito MR, Galarraga B, González-Macías J, Bouillon R, Hernández-Herrero G, Fernández-Hernando N, Arranz-Gutiérrez P, Chinchilla SP. Pérez-Castrillón JL, et al. Among authors: jodar e. J Bone Miner Res. 2021 Oct;36(10):1967-1978. doi: 10.1002/jbmr.4387. Epub 2021 Jun 24. J Bone Miner Res. 2021. PMID: 34101900 Free PMC article. Clinical Trial.
Risk factors for prediction of inadequate response to antiresorptives.
Díez-Pérez A, Olmos JM, Nogués X, Sosa M, Díaz-Curiel M, Pérez-Castrillón JL, Pérez-Cano R, Muñoz-Torres M, Torrijos A, Jodar E, Del Rio L, Caeiro-Rey JR, Farrerons J, Vila J, Arnaud C, González-Macías J. Díez-Pérez A, et al. Among authors: jodar e. J Bone Miner Res. 2012 Apr;27(4):817-24. doi: 10.1002/jbmr.1496. J Bone Miner Res. 2012. PMID: 22161773 Free article.
Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis.
Morales-Santana S, Díez-Pérez A, Olmos JM, Nogués X, Sosa M, Díaz-Curiel M, Pérez-Castrillón JL, Pérez-Cano R, Torrijos A, Jodar E, Rio LD, Caeiro-Rey JR, Reyes-García R, García-Fontana B, González-Macías J, Muñoz-Torres M. Morales-Santana S, et al. Among authors: jodar e. Maturitas. 2015 Dec;82(4):402-10. doi: 10.1016/j.maturitas.2015.08.007. Epub 2015 Aug 20. Maturitas. 2015. PMID: 26358930
Spanish consensus on treat to target for osteoporosis.
Nogués X, Nolla JM, Casado E, Jódar E, Muñoz-Torres M, Quesada-Gómez JM, Canals L, Balcells M, Lizán L. Nogués X, et al. Among authors: jodar e. Osteoporos Int. 2018 Feb;29(2):489-499. doi: 10.1007/s00198-017-4310-y. Epub 2017 Nov 24. Osteoporos Int. 2018. PMID: 29177559 Free PMC article.
Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women.
Pérez-Castrillón JL, Dueñas-Laita A, Gómez-Alonso C, Bouillon R, Jódar E, Brandi ML, González-Macías J, Quesada-Gómez JM, Olmos Martínez JM, Galarraga B, Del Pino-Montes J, Alhambra Expósito MR, Cereto Castro F, Gallego López L, Hernández-Herrero G, Fernández-Hernando N, Arranz-Gutiérrez P, Chinchilla SP. Pérez-Castrillón JL, et al. Among authors: jodar e. J Bone Miner Res. 2022 Jul;37(7):1413-1415. doi: 10.1002/jbmr.4612. Epub 2022 Jun 10. J Bone Miner Res. 2022. PMID: 35607257 Free article. No abstract available.
Inhaled steroids do not decrease bone mineral density but increase risk of fractures: data from the GIUMO Study Group.
Sosa M, Saavedra P, Valero C, Guañabens N, Nogués X, del Pino-Montes J, Mosquera J, Alegre J, Gómez-Alonso C, Muñoz-Torres M, Quesada M, Pérez-Cano R, Jódar E, Torrijos A, Lozano-Tonkin C, Díaz-Curiel M; GIUMO Study Group. Sosa M, et al. Among authors: jodar e. J Clin Densitom. 2006 Apr-Jun;9(2):154-8. doi: 10.1016/j.jocd.2005.11.005. Epub 2006 Apr 18. J Clin Densitom. 2006. PMID: 16785074
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9).
Pozzilli P, Norwood P, Jódar E, Davies MJ, Ivanyi T, Jiang H, Woodward DB, Milicevic Z. Pozzilli P, et al. Among authors: jodar e. Diabetes Obes Metab. 2017 Jul;19(7):1024-1031. doi: 10.1111/dom.12937. Epub 2017 Apr 10. Diabetes Obes Metab. 2017. PMID: 28294499 Clinical Trial.
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial.
Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, Jódar E, Kandler K, Rigas G, Wadden TA, Wharton S; STEP 5 Study Group. Garvey WT, et al. Among authors: jodar e. Nat Med. 2022 Oct;28(10):2083-2091. doi: 10.1038/s41591-022-02026-4. Epub 2022 Oct 10. Nat Med. 2022. PMID: 36216945 Free PMC article. Clinical Trial.
87 results